Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$42.05 - $47.77 $122,575 - $139,249
-2,915 Reduced 11.59%
22,233 $968,000
Q1 2022

May 13, 2022

BUY
$40.23 - $47.74 $254,816 - $302,385
6,334 Added 33.67%
25,148 $1.1 Million
Q4 2021

Feb 17, 2022

BUY
$38.88 - $45.31 $731,488 - $852,462
18,814 New
18,814 $830,000
Q3 2020

Nov 03, 2020

SELL
$38.11 - $42.99 $214,063 - $241,474
-5,617 Closed
0 $0
Q2 2020

Jul 29, 2020

SELL
$37.87 - $43.58 $352,456 - $405,599
-9,307 Reduced 62.36%
5,617 $229,000
Q1 2020

May 04, 2020

BUY
$32.47 - $48.83 $264,565 - $397,866
8,148 Added 120.25%
14,924 $565,000
Q4 2019

Jan 31, 2020

BUY
$42.0 - $48.25 $2,730 - $3,136
65 Added 0.97%
6,776 $318,000
Q3 2019

Nov 06, 2019

BUY
$40.46 - $43.52 $37,020 - $39,820
915 Added 15.79%
6,711 $286,000
Q2 2019

Aug 05, 2019

BUY
$39.4 - $42.7 $228,362 - $247,489
5,796 New
5,796 $232,000
Q4 2018

Jan 29, 2019

SELL
$37.8 - $42.69 $266,905 - $301,434
-7,061 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$39.75 - $42.69 $280,674 - $301,434
7,061 New
7,061 $284,000
Q3 2017

Nov 13, 2017

SELL
$39.44 - $41.55 $81,719 - $86,091
-2,072 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
2,072
2,072 $0

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.